Factor VIII gene variants and inhibitor risk in African American hemophilia A patients.

Saved in:
Bibliographic Details
Title: Factor VIII gene variants and inhibitor risk in African American hemophilia A patients.
Authors: Gunasekera D; Uniformed Services University of the Health Sciences, Bethesda, MD; Puget Sound Blood Center Research Institute, Seattle, WA;, Ettinger RA; Puget Sound Blood Center Research Institute, Seattle, WA;, Nakaya Fletcher S; Genomics Laboratory, Puget Sound Blood Center, Seattle, WA;, James EA; Benaroya Research Institute, Seattle, WA;, Liu M; Puget Sound Blood Center Research Institute, Seattle, WA;, Barrett JC; Central Virginia Center for Coagulation Disorders, Virginia Commonwealth University, Richmond, VA;, Withycombe J; Palmetto Health, Columbia, SC;, Matthews DC; Pediatrics/Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA; and., Epstein MS; Department of Pathology and Laboratory Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA., Hughes RJ; Department of Pathology and Laboratory Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA., Pratt KP; Uniformed Services University of the Health Sciences, Bethesda, MD; Puget Sound Blood Center Research Institute, Seattle, WA;
Corporate Authors: Personalized Approaches to Therapies for Hemophilia (PATH) Study Investigators
Source: Blood [Blood] 2015 Aug 13; Vol. 126 (7), pp. 895-904. Date of Electronic Publication: 2015 Jan 23.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first